What high risk features for stage IB NSCLC would lead you to consider adjuvant chemotherapy?  

Do you consider size > 2cm, visceral pleural invasion or vascular invasion as indications for cisplatin-based chemotherapy? 



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at IHA Hematology Oncology Consultants - Ann Arbor
I have a follow up question- In a patient with St...
Medical Oncologist at University of Michigan Medical School
The ADAURA trial included patients with stage IB d...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Siri Onclogy and hematology Infusion Service
A very appropriate answer. However, I would like t...
Sign in or Register to read more